Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nipradilol

Known as: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Adrenergic alpha-AntagonistsAdrenergic beta-AntagonistsAntihypertensive AgentsPropanolamines
Expand

Narrower (1)

K 351

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Risk factors for progression of normal‐tension glaucoma under β‐blocker monotherapy
Purpose:  To prospectively study prognostic factors for normal‐tension glaucoma (NTG) under treatment with topical β‐blocker. 
2009
2009
Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress.
PURPOSE Oxidative stress plays an important role in pathogenesis of glaucoma. The purpose of this study is to investigate the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits.
The present study was performed to evaluate the intraocular pressure (IOP)-lowering effect of nipradilol in combination with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2002
Highly Cited
2002
Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells
Purpose. To determine whether nipradilol, a new antiglaucoma drug, can protect retinal ganglion cells (RGCs) from secondary cell… Expand
Highly Cited
2002
Highly Cited
2002
Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys.
PURPOSE To investigate the effects of topical nipradilol on blood velocity in the optic nerve head (ONH) in normal humans and the… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2001
Highly Cited
2001
Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
PURPOSE To investigate the effect of nipradilol, an alpha(1),beta-blocker with a nitric oxide donative action, on N:-methyl-D… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2000
2000
Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
AIMS To study the effects of topical nipradilol, a non-selective beta blocker with alpha blocking and nitroglycerin-like… Expand
1998
1998
Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
PURPOSE To study the effects of nipradilol, a nonselective beta-blocker with alpha 1-blocking activity and nitroglycerin-like… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 2
1996
1996
Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic.
The effects of nipradilol, an ocular hypotensive drug, on isolated canine retinal central arteries and on retinal arterioles in… Expand
1985
1985
Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.
Nipradilol competitively antagonized norepinephrine- or phenylephrine-induced contractile responses of guinea-pig thoracic aorta… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE